Brain Stimulation for PTSD
Trial Summary
What is the purpose of this trial?
This study will be the first of its kind to explore the impact of continuous theta burst stimulation (cTBS) to the intraparietal sulcus (IPS) on arousal symptoms among patients with posttraumatic stress disorder (PTSD). The investigators will demonstrate that IPS cTBS results in significant reduction in arousal (measured by startle response) compared to sham cTBS, that IPS cTBS interacts with extinction training to further improve arousal, and that there is a dose/response effect of cTBS on arousal. The investigators will also demonstrate that IPS cTBS significantly improves retention of extinction learning, the experimental analogue of exposure therapy.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but it excludes those who have had recent medication changes in the past 8 weeks. This might mean you need to be stable on your current medications for at least 8 weeks before joining.
What data supports the effectiveness of the treatment Continuous Theta Burst Stimulation for PTSD?
Is theta burst stimulation (TBS) safe for humans?
Theta burst stimulation (TBS) has been studied for various psychiatric conditions and is generally considered safe, with most adverse effects being mild. However, there is a theoretical risk of seizures, so it should be used with caution, and more research is needed to fully understand its long-term safety.12467
How is continuous theta burst stimulation different from other PTSD treatments?
Continuous theta burst stimulation (cTBS) is a unique treatment for PTSD that uses magnetic pulses to stimulate specific brain areas, offering a novel approach compared to traditional therapies like medication or talk therapy. It is a form of transcranial magnetic stimulation (TMS) that is faster and has shown promise in improving symptoms of depression and PTSD, especially in cases where other treatments have not been effective.12489
Research Team
Lily A Brown, PhD
Principal Investigator
University of Pennsylvania
Eligibility Criteria
This trial is for right-handed adults aged 18-60 with PTSD, as diagnosed by the DSM-5 criteria. Participants must not have any metal implants in their body.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive continuous theta burst stimulation (cTBS) to the intraparietal sulcus (IPS) and undergo extinction training to reduce arousal symptoms
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessments of startle response and subjective distress
Treatment Details
Interventions
- Continuous Theta Burst Stimulation
- Sham Continuous Theta Burst Stimulation
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pennsylvania
Lead Sponsor